Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06895564

Proton SBRT for Spinal Metastasis

Led by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Updated on 2026-04-29

12

Participants Needed

1

Research Sites

262 weeks

Total Duration

On this page

Sponsors

S

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Lead Sponsor

S

Sibley Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a single-arm pilot study of proton stereotactic body radiotherapy (SBRT) for nonhematologic spinal metastasis in patients with complex lesions that are unable to be effectively treated with standard of care photon SBRT defined as inability to develop a photon SBRT plan that achieves adequate coverage (≥80% planning treatment volume (PTV) coverage)) with a prescription dose of 30 Gy in 5 fractions.

CONDITIONS

Official Title

Proton SBRT for Spinal Metastasis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologic or cytologic proof of nonhematologic cancer from primary or metastatic site
  • Radiographic evidence of spinal metastasis on MRI
  • Complex cases not treatable effectively with photon SBRT achieving less than 80% tumor coverage at 30 Gy in 5 fractions, including extensive paraspinal disease, epidural extension (Bilsky grade 61c), or reirradiation
  • Age 18 years or older
  • ECOG performance status 0 to 2 (Karnofsky >60%)
  • Patients of childbearing potential must use adequate contraception
  • Ability and willingness to sign informed consent
  • Awareness of the investigational nature of the study and provision of written informed consent
Not Eligible

You will not qualify if you...

  • Cases suitable for standard photon SBRT achieving at least 80% tumor coverage at 30 Gy in 5 fractions
  • Inability to receive MRI scans
  • Uncontrolled illnesses such as active infection, symptomatic heart failure, unstable angina, cardiac arrhythmias, or psychiatric/social conditions limiting study compliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21287

Actively Recruiting

Loading map...

Research Team

K

Kristin Redmond, MD

CONTACT

R

Ryan Manuel

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here